Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
This finding offers important insight into research on HIV cure therapies.
A recent NIH study found that adults have a much higher viral suppression rate than youth.
As a result, researchers in Spain are testing whether HIV med Truvada, often used as PrEP, can also prevent COVID-19.
Amid talk of “ending HIV,” we must also focus on those with the virus, says Anthony S. Fauci, MD.
Sexually transmitted infections reach all-time highs, notably among young people.
The trial will enroll healthy volunteers to test the vaccine’s safety and ability to trigger an immune response.
Interim guidance from HIVMA and AIDSinfo covers lab visits, opioid treatment programs, pregnant women and more.
Researchers used a harmless virus to deliver a gene for a broadly neutralizing HIV antibody to cells, which produced the antibody over time.
But it comes with deep cuts to Medicare, Medicaid, Social Security, cancer funds and other health and science programs.
Researchers have been searching for agents that can wake HIV from its resting state in an effort to flush out the viral reservoir.
The American Cancer Society sets the record straight.
That’s the core message of an essay by Anthony S. Fauci, MD, director of the National Institute of Allergy and Infectious Diseases.
New forms of treatment and PrEP and, hopefully, an at least partially effective vaccine will be key to fighting the epidemic in the 2020s.
That’s the focus of one of three federal grants to research and address the island’s epidemic.
Last year, the federal agency invested nearly $300 million in the search for HIV cure therapies.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.